Understand the source comparison
LIPO-C + Peptide Stack: Outcome Comparison
LIPO-C + GH Secretagogue (GHRP-2, Hexarelin) Methyl donation supports ammonia clearance from elevated protein turnover High. GH-driven anabolism increases urea cycle activity 4–6 hours 34% greater improvement in metabolic markers vs monotherapy (J Peptide Sci,
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- LIPO-C + GH Secretagogue (GHRP-2, Hexarelin)
- Methyl donation supports ammonia clearance from elevated protein turnover
- High. GH-driven anabolism increases urea cycle activity
- 4–6 hours
- 34% greater improvement in metabolic markers vs monotherapy (J Peptide Sci, 2023)
- Strong synergy. Prevents hepatic stress during dose escalation
- LIPO-C + Metabolic Peptide (Tesofensine, Survodutide)
- Choline stabilises mitochondria under elevated beta-oxidation load
- Moderate. Lipolysis generates acetyl-CoA requiring processing
- Improved fatty acid oxidation efficiency in rodent models (Metabolism, 2022)
- Recommended. Prevents oxidative stress from incomplete fat metabolism
- LIPO-C + Cognitive Peptide (Cerebrolysin, Dihexa)
- Choline supports membrane turnover during synaptogenesis
- Low. Neuroplasticity is not methylation-intensive
- 2–4 hours acceptable
- Observational data suggests enhanced cognitive outcome markers
- Moderate synergy. Primarily supports mitochondrial function
- LIPO-C + Thymalin or Cartalax
- Methyl donation supports immune cell proliferation and differentiation
- Low to moderate. Depends on immune activation state
- Limited direct evidence; theoretical synergy via methylation pathways
- Possible benefit. More data needed on immunomodulatory stacks
- LIPO-C + KPV
- Minimal mechanistic overlap. KPV acts via MSH pathways
- Minimal
- No specific timing required
- No documented interaction
- No contraindication but limited synergy